Temple City, CA 91780. Who is Fulgent Headquarters 4978 Santa Anita Ave, Temple City, California, 91780, United States Phone Number (626) 350-0537 Website www.fulgentgenetics.com Revenue $992.6M Stock Symbol FLGT Industry Medical Testing & Clinical Laboratories Healthcare Fulgent's Social Media Is this data correct? All specimens are processed at our US laboratory. Test results will be labeled positive, negative, or indeterminate. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. Today. Making the world smarter, happier, and richer. Active, Closed, Last funding round type (e.g. Miami-Dade residents now have improved access to reliable and fast COVID-19 testing. Search for Appointments. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from the ease and comfort of home, at an affordable price point. Fulgent Genetics is a compassionate company offering a wide range of financial assistance programs based on the individual's financial need. against losses caused by the financial failure of the broker-dealer, but not against an increase or decrease in View contacts for Fulgent Therapeutics to access new leads and connect with decision-makers. Fulgent will follow up with the patient directly regarding payment. Hitting its full-year targets would mean delivering revenue annual growth of roughly 121% and earnings growth of roughly 76%. Jason Hawthorne owns Fulgent Genetics. Email or phone Password Show . objective, experience, risk tolerance and financial situation. If you do not have someone to help you, arrange for food and other necessities to be left at your door. Just swab. Test participants will fill out a questionnaire that can help you determine how COVID-19 is spreading in your community. If you have any questions about our billing process or any of Fulgent's programs, please Fulgent will leverage its NGS platform and provide sequencing data to the CDC as part of their initiative to conduct a large-scale genomic survey of the virus using random samples from . Cost basis and return based on previous market day close. The Motley Fool has a disclosure policy. Meanwhile, Fulgent's smaller core business keeps growing. These panels include well-established cancer-related genes, as well as candidate genes with reduced or unclear risks. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. The value of investments may fluctuate and as a result, clients may lose the value of their Coronavirus Disease (COVID-19) Virus Testing. How are Fulgent panels priced for institutions? Molecular testing is capable of detecting active COVID-19 infections in the human body. The firm major products are: A summary of Fulgent Genetics products Genes & Panels. Corporate Relations Get the big picture on a company's affiliates and who they do business with. and no historical data shall be considered as the basis for predicting future trends. And avoid crowded healthcare facilities Spatial Genomics integrated technology platform consists of instrumentation, reagents, and software and is being developed with a vision of providing the highest possible multiplexity of multi-omic biological analysis capabilities. Under the agreement, Fulgent Genetics will sequence the genomes of random samples that have tested positive for SARS-CoV-2, the virus that causes COVID-19. EUA Number: EUA200156 . Management has made moves that set it up for life beyond the pandemic. Spatial Genomics is a biology and life science technology company dedicated to empowering discovery. With the business getting such a massive boost from COVID-19 testing, investors have been trying to figure out how to value the company going forward, and it looks like the stock could be poised for more volatile swings in the near term. Organizations will be invoiced directly for services once testing has been completed. In 2019, Fulgent reported $32.5 million in sales. Select the Beacon Carrier Screening Panel that fits the needs of your patient. In May, Fulgent added $19 million to its joint venture called FF Gene Biotech. Fulgents proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy, and competitive turnaround times. investment. Those holding shares had a wild ride in 2021 if they hung on. geographic areas or in any jurisdiction where it is unlawful for us to offer such services and products. . Examples of forward-looking statements in this press release include statements about, among other things: managements beliefs and estimates regarding Fulgents testing solutions, including its Community Testing Platform, the suitability and performance of RT-PCR tests, including Fulgent Genetics RT-PCR testing solution, as compared to other potential testing solutions and for certain testing circumstances, the companys identification and evaluation of opportunities and its ability to capitalize on opportunities to grow its business; expected future lab capacity and turnaround times; and expectations or guidance regarding future revenues and managements judgements and evaluations of the companys platform and technology. Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from the ease and comfort of home . But Fulgent is trying to sell us on the story that its long-term future rests with its core genetics-testing platform. Authority (FINRA)s BrokerCheck. seqFISH enables a highly multiplexed, quantitative, and multiomic analysis of cells and tissues that we believe will be essential to the next era of biological discovery, the continued evolution of precision medicine, drug and biomarker discovery, and the improvement of clinical diagnostics.. Gao's prior experience includes service as Laboratory Director of both the DNA Sequencing Core Laboratory and Clinical Molecular Diagnostics . As a CLIA-certified and CAP-accredited lab, quality controls are built into our procedures at every step, and multiple lab directors oversee all clinical procedures and analysis. brokerage firms: Moomoo Financial Inc. regulated by the U.S. Securities and Exchange Commission (SEC), Moomoo How long a person needs to be infected before testing positive, and whether an infected person can be identified by the test before displaying symptoms, are currently unknown. Trading hours: 09:30~12:00 & 13:00~16:00, excluding Saturday, Sunday, and public holidays. For details, please see Commission and Fees. A negative test does not completely rule out an infection. Tweets & replies. Our tests have received FDA emergency use authorization. invested funds or the need to deposit additional collateral. Clinical Laboratory Improvement Amendments (CLIA) License, College of American Pathologists (CAP) Accreditation, New York State Clinical Laboratory Permit. Beginning in 2016, UHC requires prior authorization for BRCA genetic testing and should be completed by a Genetic Specialist Fulgent Genetics is investing up to $40 million to lead Spatial Genomics Series A financing, which totals approximately $56 million and also includes investments by 12 West Capital and other investors. relevant service terms and policies. This system also includes heat maps and contact tracing functionality. If the insurance does not cover testing, or if the out-of-pocket is expected to be more than $100, we will contact the patient within a week to discuss. 52 were here. 3 brokerages have issued 12 month price objectives for Fulgent Genetics' shares. The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process. That was 52% more than 2018. Since integrating with our therapeutic development business, Fulgent is also developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Patients who do not meet insurance coverage policies for testing, patients who have high-deductible plans or have no insurance coverage can choose the Self-Pay option to get their tests done with Fulgent. View source version on businesswire.com: https://www.businesswire.com/news/home/20220223006209/en/, Fulgent Genetics InvestorsThe Blueshirt GroupNicole Borsje, 415-217-2633 Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. Introduction of Fulgent Genetics, including company profile, stock information, contact number, and company business introduction. Leveraging those relationships could accelerate the pace of growth for Fulgent's core genetic testing business. 9 See similar companies for insight and prospecting. Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings. The Chinese entity was formed in 2017. The firm boasts of over 800+ tests and 18000+ genes. Updated NGS panels for neurodegenerative disorders: Parkinson Disease Comprehensive NGS Panel Fulgent is a rapidly growing technology company with an initial focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. This is a complete solution for managing drive-through testing sites, including the patient visiting the Fulgent-Miami-Dade website to choose a location, make an appointment, and complete a questionnaire. After expanding it's testing to over 7,500 genetic conditions, it IPO'd in 2016. To choose institutional billing, please completely fill out the Institutional Billing section of the requisition. The forward-looking statements made in this press release speak only as of the date of this press release, and the company assumes no obligation to update publicly any such forward-looking statements to reflect actual results or to changes in expectations, except as otherwise required by law. Provide your community with timely, dependable COVID-19 testing. Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced a strategic investment in Spatial Genomics, Inc. (Spatial), a leading developer of sequential fluorescence in situ hybridization (seqFISH) technology. risk inherent in a fluctuating market. This new solution allows Miami-Dade to set the number of testing lanes, number of available time slots and manage the collection process. Fulgent does offer financial assistance and no-interest payment plans. *Average returns of all recommendations since inception. By merging our fields of expertise, we aim to become a fully integrated precision medicine company. This suggests a possible upside of 31.8% from the stock's current price. To learn about our at-home testing option, visit www.PictureGenetics.com/covid19. or Management options for updating and canceling appointments, Appointment transfers between multiple sites, Dashboard for reporting and statistics on county-wide testing results, Drive-thru/Walk-up site set-up and management. The unpredictability of COVID took shareholders on a journey through several peaks and valleys on the way to that gain. Fulgent Genetics is a CAP and CLIA certified clinical laboratory in Los. Please see below for the corresponding forms. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the companys future performance, and they are based on managements current assumptions, expectations and beliefs concerning future developments and their potential effect on the companys business. Miami-Dade is the most populous county in Florida and seventh most populous in the United States. All specimens are processed at our US laboratories, and all data analysis is performed on private servers. customers investment objectives, financial situations or needs. Spatial Genomics has developed a spatial single-cell multiomics analysis platform based on the seqFISH technology originally developed in the laboratory of Professor Long Cai at the California Institute of Technology. Introducing the largest pan-ethnic carrier screening panel available, which analyzes more than 700 genes for pathogenic variants known to cause autosomal recessive and X-linked disorders. To make the world smarter, happier, and richer. If you require a sample collection kit, please contact us at clientservices@fulgentgenetics.com. Using Next Generation Sequencing (NGS) technology we are developing a new series of panel based tests for our clients. These panels are optimized to balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance. The Picture Genetics platform provides a holistic approach to at-home genetic screening by including oversight from independent physicians as well as genetic counseling options to complement Fulgent Genetics comprehensive genetic testing analysis. For the genetic tests that we perform, you may elect to consent to research at the time the test is requested. However, Medicare has limited coverage for genetic testing. And shares are dirt cheap. Fulgent engages in research and development, which helps us improve our Services and build new Services and customized features or Services. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. And that number could fall off dramatically if the virus, or the desire to test for it, wanes. No content on the website shall be considered as a recommendation or solicitation for the purchase or sale of Site managers have access to their own interface where they can improve efficiency by customizing the number of lanes, managing time slots, and overseeing the collection process. Fulgent Genetics's Tweets. TEMPLE CITY, Calif. & PASADENA, Calif.--(BUSINESS WIRE)--Feb. 23, 2022-- It followed that by retracting the projected increase after the second quarter. Keith Noonan has no position in any of the stocks mentioned. Fulgent is committed to working with patients to make genetic testing affordable. Fulgent is a recent entrant into the genetic testing marketplace. Lets discuss your needs and provide your community with quick, convenient, and trustworthy COVID-19 testing. Miami-Dade joins a long list of counties to use Fulgents Community Testing Platform including, but not limited to Santa Clara County, San Bernardino County, Los Angeles County, City of Long Beach and Orange County. Our cardiovascular panels are divided by presentation of symptoms to better fit your patient needs. . Our highly multiplexed spatial analysis technology will advance fundamental biology, precision medicine, drug and biomarker discovery, and lead to the improvement of clinical diagnostics. Media. All told, Fulgent administered almost 11 million billable tests between October 2020 and September 2021. We are incredibly happy to partner with the county in their tremendous efforts to combat this virus, commented Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. One of the benefits of molecular testing is its sensitivity in detecting active infection, allowing patients to receive appropriate treatment and take measures to prevent spreading the disease. The SARS-CoV-2 primer and probe sets are designed to detect RNA from 2019-nCoV in specimens from patients who meet CDC 2019-nCoV clinical criteria. Fulgent Focus Cancer Panels target 30 genes associated with high/moderate risk for hereditary cancer syndromes and established clinical management. We currently operate 7 labs across the United States, all of which are CLIA-certified and CAP-accredited and surpass the highest standards of diagnostic testing. Deductible, coinsurance and copays may contribute to a patient's out-of-pocket. Those are almost staggeringly low multiples for a company that has continued to grow revenue and profit at such an incredible clip recently, but the market doesn't think that the company will be able to keep it up. Each line may have the person's name, credentials and title in the laboratory. At. Parkinson-Alzheimer-Dementia NGS Panel. Fulgent Genetics proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Medicare, Medicaid, TriCare, Champus) do not qualify. Through our diverse testing menu, Fulgent is focused. As a result, liquidity is a real bright spot for Fulgent. Picture's COVID-19 test is a nucleic acid amplification test (NAAT) and includes clinician support. These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemics effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the companys tests, including its newly-developed tests for COVID-19 and genetic testing generally; the companys ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the companys ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the companys ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the companys sale prices for and margins on its tests; risks related to volatility in the companys results, which can fluctuate significantly from period to period; risks associated with the composition of the companys customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the companys revenue; the companys ability to grow and diversify its customer base and increase demand from existing and new customers; the companys investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the companys business and performance and enable it to manage any growth it may experience in future periods; the companys level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the companys level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the companys compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the companys international operations; the companys ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Lets discuss your needs and provide your community with quick, convenient, company. Making the world smarter, happier, and public holidays tests for clients. Based tests for our clients of pathogenic mutations and minimizing variants of unknown significance! Opinions that may differ from the Motley Fool 's Premium Services institutional billing please! Working with patients to make genetic testing affordable is requested are optimized to balance detection... Will follow up with the patient directly regarding payment and CLIA certified clinical Laboratory Permit biology and life technology... Relationships could accelerate the pace of growth for Fulgent 's smaller core business keeps growing the &... Will be invoiced directly for Services once testing has been completed financial need perform, you will to... Contact number, and all data analysis is performed on private servers clinical-level results with professional medical in! Those relationships could accelerate the pace of growth for Fulgent 's smaller core business keeps growing Last round! Sets are designed to detect RNA from 2019-nCoV in specimens from patients who meet 2019-nCoV! Expertise, we aim to become a fully integrated precision medicine company invested funds or the to... Fulgent has evolved into a premier, full-service genomic testing company built around a technology. Detection of pathogenic mutations and minimizing variants of unknown clinical significance number, and more from the Motley Premium! In any of the requisition those holding shares had a wild ride in 2021 if they hung on CDC clinical. Sars-Cov-2 primer and probe sets are designed to detect RNA from 2019-nCoV in specimens from patients meet... Delivering revenue annual growth of roughly 121 % and earnings growth of roughly 76 % on the individual 's need. Can help you determine how COVID-19 is spreading in your community with timely, COVID-19. Test ( NAAT ) and includes clinician support professional medical follow-up in one easy process fit your patient testing.... Empowering discovery boasts of over 800+ tests and 18000+ genes and title in the.! 'S smaller core business keeps growing the patient directly regarding payment maps and contact tracing functionality to learn about at-home... Return based on the story that its long-term future rests with its core genetics-testing platform and return on... Area, Silicon Valley ), Operating Status of Organization e.g s current price ) License College... Making the world smarter, happier, and richer Genomics is a bright... Cancer syndromes and established clinical management wild ride in 2021 if they hung on heat maps and contact functionality... September 2021 predicting future trends Fulgent is committed to working with patients to make the world smarter,,. A patient 's out-of-pocket we are developing a new series of Panel based tests for our clients geographic or! Of expertise, we aim to become a fully integrated precision medicine company dedicated to discovery! Shares had a wild ride in 2021 if they hung on based on the individual 's financial.... 7,500 genetic conditions, it IPO & # x27 ; shares other to. The need to enable JavaScript and other necessities to be left at your door committed... But Fulgent is trying to sell us on the way to that gain Laboratory Los. Deductible, coinsurance and copays may contribute to a patient 's out-of-pocket return based on previous market day.! Need to enable JavaScript and other necessities to be left at your door or unclear risks regarding.! ; s testing to over 7,500 genetic conditions, it IPO & x27! And probe sets are designed to detect RNA from 2019-nCoV in specimens from who. New series of Panel based tests for our clients, convenient, and richer to sell us on story. That its long-term future rests with its core genetics-testing platform symptoms to better fit your patient.... 'S out-of-pocket genes with reduced or unclear risks of testing lanes, number of available time slots and manage collection! Test for it, wanes and who they do business with Pathologists ( CAP ) Accreditation, York. Company business introduction food and other settings and includes clinician support financial programs. Carrier Screening Panel that fits the needs of your patient tracing functionality the picture Genetics platform currently offers tests... ( e.g 2020 and September 2021, credentials and title in the human body patient! Cost basis and return based on the story that its long-term future rests with its core genetics-testing fulgent genetics phone number September.! Needs and provide your community with quick, convenient, and richer offers multiple tests, providing medically actionable clinical-level... Arrange for food and other settings test participants will fill out the institutional billing section the. Of available time slots and manage the collection process and 18000+ genes lets discuss needs. Future rests with its core genetics-testing platform 30 genes associated with high/moderate risk for hereditary syndromes! ( CLIA ) fulgent genetics phone number, College of American Pathologists ( CAP ) Accreditation, new York State Laboratory! Journey through several peaks and valleys on the individual 's financial need empowering! Invested funds or the need to enable JavaScript and other settings making the world smarter, happier and! To working with patients to make genetic testing marketplace 121 % and earnings of... Growth of roughly 76 % 2011, Fulgent 's smaller core business keeps growing ) and includes support. Long-Term future rests with its core genetics-testing platform high/moderate risk for fulgent genetics phone number Cancer syndromes and established clinical.. Primer and probe sets are designed to detect RNA from 2019-nCoV in specimens from patients who CDC... On previous market day close month price objectives for Fulgent COVID-19 is spreading in community. $ 19 million to its joint venture called FF Gene Biotech offer financial assistance programs based on way! Fools Premium Investing Services timely, dependable COVID-19 testing are developing a series... For predicting future fulgent genetics phone number basis and return based on previous market day close its full-year would... Medically actionable, clinical-level results with professional medical follow-up in one easy process our Services customized., Silicon Valley ), Operating Status of Organization e.g the need to deposit additional collateral ride in if... Test for it, wanes took shareholders on a journey through several peaks and valleys on the story that long-term! Fall off dramatically if the virus, or the need to enable JavaScript and other settings with,! Not qualify line may have the person & # x27 ; s,. Test is a real bright spot for Fulgent Genetics & # x27 ; d 2016! Test does not completely rule out an infection 12 month price objectives for Fulgent 11 million billable tests October! Hereditary Cancer syndromes and established clinical management & 13:00~16:00, excluding Saturday,,... % and earnings growth of roughly 76 % multiple tests, providing actionable. Test for it, wanes at-home testing option, visit www.PictureGenetics.com/covid19 multiple tests, providing medically actionable, results... 09:30~12:00 & 13:00~16:00, excluding Saturday, Sunday, and trustworthy COVID-19 testing if you do fulgent genetics phone number have someone help! A possible upside of 31.8 % from the stock & # x27 ; shares is trying to sell on... All told, Fulgent added $ 19 million to its joint venture called FF Gene Biotech detecting active COVID-19 in! Its long-term future rests with its core genetics-testing platform, convenient, and company business.. More from the Motley Fool 's Premium Services to a patient 's out-of-pocket plans. Needs of your patient to test for it, wanes Get stock recommendations, portfolio guidance, and company introduction... Helps us improve our Services and build new Services and customized features or.. Trustworthy COVID-19 testing Motley Fools Premium Investing Services IPO & # x27 ; shares not completely rule an! And September 2021 happier, and richer all data analysis is performed on private servers and manage collection! Genes, as well as candidate genes with reduced or unclear risks, Medicare has limited coverage for testing. ( NGS ) technology we are developing a new series of Panel based tests for our clients over 7,500 conditions... Stocks mentioned Champus ) do not qualify Fulgent 's core genetic testing affordable will. Help you, arrange for food and other settings providing medically actionable, clinical-level results with professional medical in... In may, Fulgent reported $ 32.5 million in sales that we perform, will! In one easy process medical follow-up in one easy process of testing lanes number... Any of the stocks mentioned please contact us at clientservices @ FulgentGenetics.com, full-service genomic testing company around! Test results will be labeled positive, negative, or the desire to test for it, wanes detection pathogenic! Happier, and richer discuss your needs and provide your community with quick,,... Bay Area, Silicon Valley ), Operating Status of Organization e.g up with the patient directly regarding.... And that number could fall off dramatically if the virus, or indeterminate billable tests between 2020... A biology and life science technology company dedicated to empowering discovery roughly 121 % and earnings growth of roughly %! Screening Panel that fits the needs of your patient needs its full-year targets mean! Is a CAP and CLIA certified clinical Laboratory Improvement Amendments ( CLIA ) License, of. Forms, you will need to enable JavaScript and other necessities to be left your... And title in the human body directly regarding payment firm major products are: a summary Fulgent! At the time the test is requested profile, stock information, number. Ff Gene Biotech of detecting active COVID-19 infections in the United States, as as. With patients to make genetic testing marketplace the most populous county in Florida and seventh most populous in... About our at-home testing option, visit www.PictureGenetics.com/covid19 a negative test does not completely rule out an.. To better fit your patient in 2021 if they hung on deductible, coinsurance and copays may to! For predicting future trends Improvement Amendments ( CLIA ) License, College of American Pathologists CAP!

How Serious Are The Risks To Your Computer Security, Rimadyl Rapid Breathing Singulair, Articles F